Sign Up to like & get recommendations! 1
Published in 2018 at "Journal of Clinical Apheresis"
DOI: 10.1002/jca.21634
Abstract: A consistent and reproducible depletion technique is crucial for the successful transplantation of an ex vivo depleted graft. Our aim was to evaluate the efficacy of an ex vivo technique for depletion of αβ+ T… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "International Journal of Hematology"
DOI: 10.1007/s12185-017-2317-y
Abstract: In the present study, we sought to analyze the risk factors following haploidentical hematopoietic stem cell transplantation (haplo-HSCT) in children with high-risk acute leukemia. We retrospectively reviewed data from 73 children with high-risk leukemia. Univariate… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Biology of Blood and Marrow Transplantation"
DOI: 10.1016/j.bbmt.2019.12.618
Abstract: Background Optimal myeloablative conditioning (MAC) in the setting of haploidentical hematopoietic cell transplantation (haplo-HCT) with post-transplant cyclophosphamide (PTCy) is unknown. We studied the outcomes of total body irradiation (TBI) vs. chemotherapy (CT) based MAC regimens… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Transplantation proceedings"
DOI: 10.1016/j.transproceed.2018.10.028
Abstract: Graft-vs-host disease (GVHD) is one of the biggest challenges in haploidentical hematopoietic stem cell transplantation. Antithymocyte globulins (ATGs) are widely used to overcome GVHD, but excessive immunosuppression increases the chances of relapse and infection following… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "European Journal of Haematology"
DOI: 10.1111/ejh.13332
Abstract: Haploidentical hematopoietic stem cell transplant (haplo‐SCT) has been associated with higher rates of graft rejection, and a higher dose of CD34+ cell dose is frequently requested. We aim to explore the impact of CD34+ cell… read more here.
Sign Up to like & get recommendations! 0
Published in 2023 at "Transplant Infectious Disease"
DOI: 10.1111/tid.14054
Abstract: This study aims to observe and analyze the clinical characteristics and prognosis of adenovirus (ADV) infection diagnosed by metagenomic next‐generation sequencing (mNGS) after haploidentical hematopoietic stem cell transplantation (Haplo‐HSCT), which was performed following Beijing Protocol. read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Blood advances"
DOI: 10.1182/bloodadvances.2022007735
Abstract: Haploidentical hematopoietic stem cell transplantation (haplo-HSCT) with post-transplant cyclophosphamide is a curative treatment for many hematological malignancies, yet a majority of patients still suffers from recurrent infections. Post-transplant infusion of memory T cells could potentially… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2020.00147
Abstract: Over the last decade, the development of multiple strategies to allow the safe transfer from the donor to the patient of high numbers of partially HLA-incompatible T cells has dramatically reduced the toxicities of haploidentical… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1017850
Abstract: Currently, the graft-versus-host disease (GVHD) prophylaxis consists of an immunosuppressive therapy mainly based on antithymocyte globulin (ATG) or post-transplant cyclophosphamide (PTCy). GVHD remains a major complication and limitation to successful allogeneic haploidentical hematopoietic stem cell… read more here.
Sign Up to like & get recommendations! 1
Published in 2023 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2023.1064190
Abstract: Background Prognosis of children with primary disseminated or metastatic relapsed sarcomas remains dismal despite intensification of conventional therapies including high-dose chemotherapy. Since haploidentical hematopoietic stem cell transplantation (haplo-HSCT) is effective in the treatment of hematological… read more here.